97 related articles for article (PubMed ID: 7539183)
1. Benign prostatic hyperplasia. Hormonal treatment.
McConnell JD
Urol Clin North Am; 1995 May; 22(2):387-400. PubMed ID: 7539183
[TBL] [Abstract][Full Text] [Related]
2. Androgen ablation and blockade in the treatment of benign prostatic hyperplasia.
McConnell JD
Urol Clin North Am; 1990 Aug; 17(3):661-70. PubMed ID: 1695786
[TBL] [Abstract][Full Text] [Related]
3. The role of combination medical therapy in benign prostatic hyperplasia.
Greco KA; McVary KT
Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
[TBL] [Abstract][Full Text] [Related]
4. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
Naslund MJ; Miner M
Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
[TBL] [Abstract][Full Text] [Related]
5. 5alpha-reductase inhibitors/finasteride.
Stoner E
Prostate Suppl; 1996; 6():82-7. PubMed ID: 8630236
[TBL] [Abstract][Full Text] [Related]
6. Benign prostatic hyperplasia: drug and nondrug therapies.
Bruskewitz RC
Geriatrics; 1992 Dec; 47(12):39-42, 45. PubMed ID: 1280242
[TBL] [Abstract][Full Text] [Related]
7. Medical management of benign prostatic hyperplasia: a review.
Magoha GA
East Afr Med J; 1996 Jul; 73(7):453-6. PubMed ID: 8918007
[TBL] [Abstract][Full Text] [Related]
8. A prospective randomized trial evaluating tissue effects of finasteride therapy in benign prostatic hyperplasia.
Feneley MR; Span PN; Schalken JA; Harper M; Griffiths K; Holmes K; Kirby RS
Prostate Cancer Prostatic Dis; 1999 Dec; 2(5/6):277-281. PubMed ID: 12497174
[TBL] [Abstract][Full Text] [Related]
9. Is transurethral microwave thermotherapy an alternative to medical therapy for patients with benign prostatic hyperplasia?
Djavan B
Tech Urol; 2000 Dec; 6(4):300-6. PubMed ID: 11108570
[TBL] [Abstract][Full Text] [Related]
10. Finasteride in the treatment of patients with moderate symptoms of benign prostatic hyperplasia.
Magoha GA
East Afr Med J; 1998 May; 75(5):260-3. PubMed ID: 9746993
[TBL] [Abstract][Full Text] [Related]
11. [Current drug therapy of benign prostatic hyperplasia].
Schmidbauer CP; Madersbacher S
Wien Med Wochenschr; 1996; 146(8):161-4. PubMed ID: 8767400
[TBL] [Abstract][Full Text] [Related]
12. [Benign hypertrophy of the prostate: which treatment, for whom?].
Schulman C
Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
[TBL] [Abstract][Full Text] [Related]
13. [Benign prostatic hyperplasia: patients' perception of medical treatment and their expectations. Results of a french survey involving patients treated with finasteride].
Teillac P
Therapie; 2002; 57(5):473-83. PubMed ID: 12611202
[TBL] [Abstract][Full Text] [Related]
14. The role of sex steroids in the pathogenesis and maintenance of benign prostatic hyperplasia.
Levine AC; Kirschenbaum A; Gabrilove JL
Mt Sinai J Med; 1997 Jan; 64(1):20-5. PubMed ID: 8997072
[TBL] [Abstract][Full Text] [Related]
15. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
Miner M; Rosenberg MT; Perelman MA
Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
[TBL] [Abstract][Full Text] [Related]
16. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
Miller N; Smolkin ME; Bissonette E; Theodorescu D
Cancer; 2005 Jun; 103(12):2499-506. PubMed ID: 15852361
[TBL] [Abstract][Full Text] [Related]
17. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002).
Vela-Navarrete R; Gonzalez-Enguita C; Garcia-Cardoso JV; Manzarbeitia F; Sarasa-Corral JL; Granizo JJ
BJU Int; 2005 Nov; 96(7):1045-8. PubMed ID: 16225526
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
DiSantostefano RL; Biddle AK; Lavelle JP
BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
[TBL] [Abstract][Full Text] [Related]
19. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
[TBL] [Abstract][Full Text] [Related]
20. Current treatment of BPH.
Roylance P; Gibelin B; Espié J
Biomed Pharmacother; 1995; 49(7-8):332-8. PubMed ID: 8562858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
